Immunic to Host MS R&D Day and Participate in Investor Confe

NEW YORK, April 4, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Russia , Ukraine , San Francisco , California , United States , Hella Kohlhof , Andreas Muehler , Edna Kaplan , Paula Schwartz , Jessica Breu , Daniel Vitt , Exchange Commission , Immunic Inc , Sclerosis Ms Research , Nasdaq , Hotel Nikko , Development Rd Day , Rx Communications Group , Multiple Sclerosis , Chief Executive Officer , Chief Medical Officer , Chief Scientific Officer , Accelerating Bio Innovation , Private Securities Litigation Reform Act , Middle East , Annual Report , President Investor Relations , Markets ,